Motherwort Heart Rhythm Supplement: The Herb Named After Lions

The Oasis Health Journal · Submitted August 11, 2026 · 3:02 PM EDT

By June Mackerel · Edited by Colette Ward

Motherwort is a perennial herb in the mint family, native to Asia and southeastern Europe, though it has since made itself rather at home in temperate regions worldwide. The botanical name is Leonurus cardiaca, which translates roughly to 'lion-hearted'. One imagines the naming committee felt they were onto something.

The plant has been used traditionally for cardiovascular complaints and what the historical literature describes, with admirable delicacy, as gynaecological afflictions. The herb appears to have been assigned a rather broad portfolio. Whether it delivered on all fronts is a separate question entirely.

The current interest in the motherwort heart rhythm supplement centres on its purported effects on arrhythmias through modulation of cardiac nerve signalling. The evidence, as we shall see, is rather less lion-hearted than the name suggests.

What The Research Actually Measured (Not What The Influencer Said)

A 2020 review published in the Journal of Traditional and Complementary Medicine compiled information on plants and herbal components with antiarrhythmic activities. The paper identified thirty-six herbs or derivatives that demonstrated effects in animal and cellular models. Motherwort cardiovascular support was among them, nestled between sophocarpine and something called ajmaline, which sounds like a condition rather than a cure.

The proposed mechanism involves alterations in ionic channels during various phases of the cardiac action potential. These changes affect amplitude, duration, effective refractory period, maximum velocity, resting membrane potential, or intracellular calcium concentration. Which is the technical way of saying the compound appears to interfere with the electrical signalling that governs how heart muscle contracts. One does hope it interferes in the right direction.

The review noted that agents which prolong action potential duration and effective refractory period, such as dauricine and sophocarpine, seemed particularly beneficial. It added the rather important qualifier that this would require more comprehensive studies to confirm efficacy and safety.

One assumes that means the comprehensive studies have not yet been done.

The same review issued a warning about potential interactions. Some herbal agents used for cardiovascular purposes, including hawthorn and ginseng, may boost the pro-arrhythmogenic effect of cardiac glycosides. Which is to say they might make your prescribed heart medication more dangerous rather than less. The motherwort heart rhythm supplement question becomes rather more complicated when one considers the rest of the pharmaceutical landscape, which was presumably already there when you started.

The Leonurus Herb Heart Health Portfolio (Mostly Mice and Considerable Optimism)

A 2018 phylogenetic analysis published in Pharmaceutical Biology reconstructed the molecular relationships of one hundred and thirty-nine plant species in seventy-one families with cardiovascular applications. The Lamiaceae family, to which motherwort belongs, was identified as exhibiting anticoagulant and thrombolytic effects within the family group. The study suggested this clustering might reflect shared phytochemistry due to common ancestry, which is a lovely thought, though one notes that family resemblance does not guarantee individual competence.

The authors proposed that species within these families which had not yet been tested might contain undiscovered compounds with similar bioactivity. Which is optimistic. One could equally propose that they might not.

A 2019 review in BioMed Research International provided an update to the European Medicines Agency assessment report on Leonurus cardiaca, originally issued in 2010. The update noted that progress had been made in the intervening eight years. It did not specify what sort of progress, or toward what endpoint, or frankly whether anyone involved had actually changed their mind about anything.

The review confirmed the historical use of the plant as a cardiotonic and for treating gynaecological conditions, including amenorrhea, dysmenorrhea, and menopausal anxiety. The current evidence supporting these traditional applications was described as requiring further study.

Which is progress of a kind, I suppose.

The Phytochemistry (Verbascoside, Genkwanin, and Thirty-Three Milligrams of Hope)

A 2026 study published in Foods measured the chlorogenic acid content of water infusions of motherwort prepared using four different methods. The median concentration was five hundred and twenty-seven micrograms per one hundred millilitres. The total phenol content per glass was thirty-two point eight eight milligrams. The antioxidant properties, measured via DPPH test and expressed as Trolox equivalent, had a mean median of thirty-three point six five milligrams per litre.

I have copied those numbers exactly as published, though I confess I have no idea whether thirty-three point six five milligrams per litre is impressive or whether one could achieve the same effect by leaving a single blueberry in a bathtub overnight.

The authors concluded that the method of preparation affects chlorogenic acid and phenol content, though the changes did not significantly affect antioxidant properties. One imagines the tea drinkers of the world will adjust their kettles accordingly.

A separate 2026 study in Molecules characterised ethanol, methanol and aqueous extracts of four Leonurus species, including L. cardiaca. HPLC-MS/MS analysis identified verbascoside, genkwanin and caffeoylquinic acids as major constituents. L. cardiaca displayed the highest antioxidant profile, with an EC50 of zero point one one seven milligrams per millilitre for DPPH and two point seven three one millimolar Trolox for ABTS, which I am told is very good, though I could not tell you compared to what.

The extracts demonstrated notable anticandidal activity, with minimum inhibitory concentrations of zero point one to one milligram per millilitre, and negligible to moderate antibacterial effects. They also showed varying levels of activity against breast and glioma cancer cell lines, though the authors noted these effects differed in toxicity compared to lung cells.

One assumes this means the extracts were not uniformly lethal, which is reassuring in its way.

The Alkaloids (Now With Mast Cell Suppression in Ovalbumin-Exposed Mice)

A 2026 study in Frontiers in Pharmacology investigated total alkaloids of Leonurus, extracted from Leonurus japonicus rather than L. cardiaca, in an ovalbumin-induced asthma mouse model. The treatment significantly alleviated allergic symptoms, reduced airway hyperresponsiveness and decreased lung mast cell infiltration, which I imagine was rather a relief for the mice.

Transcriptomic analysis revealed downregulation of hypoxia-related pathways, particularly hypoxia-inducible factor-1α. The alkaloids suppressed HIF-1α protein expression, reduced mast cell degranulation and decreased Th2 cytokines both in vivo and in vitro. The effect was weakened by HIF-1α overexpression but potentiated by the pharmacological inhibitor YC-1, which sounds like a droid from a film I have not seen.

The authors concluded that the alkaloids alleviate allergic asthma by suppressing HIF-1α-mediated mast cell activation. Which is interesting, though one notes this was mice with induced asthma, not humans with naturally occurring arrhythmias. The translational distance is not trivial. It is also not the same plant, though I suppose they are cousins.

The Natural Heart Rhythm Balance Question (Still Awaiting a Human Being)

A 2026 narrative review in Biomedicines examined plant species from Romanian flora with anxiolytic and antidepressant potential. Leonurus cardiaca was included in the analysis. The review noted that current evidence for motherwort is derived mainly from preclinical studies or traditional use, rather than robust clinical trials, which is the academic way of saying we have checked the folklore and the mice, but not the people.

For motherwort specifically, the review confirmed historical use for cardiovascular conditions and for gynaecological afflictions including amenorrhea, dysmenorrhea, menopausal anxiety, and postpartum depression. Which is quite the list. One imagines the plant was kept rather busy.

The proposed mechanisms of action include modulation of neurotransmitter activity, antioxidant and anti-inflammatory effects, and regulation of the hypothalamic-pituitary-adrenal axis. The authors concluded that phytotherapy represents a promising complementary approach, though the strength of evidence varies considerably among species. Clinical data, they noted, remain limited.

Which brings us to the central problem with the motherwort heart rhythm supplement question.

The compound has effects in animal models and cellular assays. It modulates ionic channels. It contains measurable quantities of chlorogenic acid and phenols. But a human trial demonstrating that it safely improves heart rhythm in people with diagnosed arrhythmias does not appear to exist in the accessible literature. Or the inaccessible literature. Or, as far as I can tell, anywhere a person with a heartbeat might reasonably look.

One might take motherwort for its natural heart rhythm properties if one felt optimistic about extrapolating from mice. One might equally decide to wait for the comprehensive human studies, which may arrive in eight years, or eighty, or never.

The herb has been used traditionally for centuries, which suggests it has not killed anyone in alarming numbers. Whether it has helped anyone in clinically significant numbers is another matter entirely.

The historical record suggests water infusions, though the 2026 study indicates that preparation method affects phytochemical content, so your mileage may vary depending on whether you are the sort of person who owns a thermometer for tea. As for dosage, the literature does not provide a clear answer, which one imagines is because the efficacy question has not been definitively settled, and it is rather difficult to dose something when you do not know what it is supposed to do.

The motherwort leonurus extract sits in that rather awkward category of traditional remedies with plausible mechanisms, measurable compounds and entirely theoretical benefits in humans. The lion-hearted name remains, carved into the botanical record in Latin. The lion-hearted evidence does not.

This article is education and reporting on published research. It is not medical advice, and nothing here is intended to diagnose, treat, cure or prevent any disease. Talk to your own clinician about your own situation.

Sources

1. A review on plants and herbal components with antiarrhythmic activities and their interaction with current cardiac drugs, Journal of traditional and complementary medicine (2020).
2. Leonurus cardiaca L. as a Source of Bioactive Compounds: An Update of the European Medicines Agency Assessment Report (2010), BioMed research international (2019).
3. The predictive utility of the plant phylogeny in identifying sources of cardiovascular drugs, Pharmaceutical biology (2018).
4. Water Infusions of Motherwort (<i>Leonurus cardiaca</i>) as a Source of Chlorogenic Acid and Antioxidant Properties, Foods (Basel, Switzerland) (2026).
5. Chemical Composition and Bioactivities of Turkish <i>Leonurus</i> Species (Lamiaceae) Extracts: Antioxidant, Antimicrobial, and Antiproliferative Potential, Molecules (Basel, Switzerland) (2026).
6. Wild Flora Species from Romania with Anxiolytic and Antidepressant Potential: A Global Perspective-Narrative Review, Biomedicines (2026).
7. Total alkaloids of <i>Leonurus</i> alleviate allergic asthma and inflammation responses by inhibiting hypoxia-induced factor-1⍺-mediated mast cell activation, Frontiers in pharmacology (2026).